Valuation: Myomo, Inc.

Market Cap 34.77M 30.48M 28.17M 25.91M 48.89M 3.35B 49.68M 337M 132M 1.64B 131M 128M 5.65B P/E 2026 *
-2.94x
P/E 2027 * -3.78x
Enterprise Value 34.77M 30.48M 28.17M 25.91M 48.89M 3.35B 49.68M 337M 132M 1.64B 131M 128M 5.65B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.69x
Free-Float
89.54%
Yield 2026 *
-
Yield 2027 * -
1 day-5.27%
1 week-18.18%
Current month-13.46%
1 month-29.69%
3 months+0.04%
6 months-8.15%
Current year-1.10%
1 week 0.88
Extreme 0.8801
1.14
1 month 0.88
Extreme 0.8801
1.41
Current year 0.6
Extreme 0.605
1.59
1 year 0.6
Extreme 0.605
2.2
3 years 0.5
Extreme 0.4966
7.17
5 years 0.37
Extreme 0.369
14.35
10 years 0.37
Extreme 0.369
695.89
Manager TitleAgeSince
Chief Executive Officer 72 2011-06-30
Director of Finance/CFO 64 2019-02-17
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2016-07-31
Director/Board Member 79 2012-02-29
Director/Board Member 80 2014-08-31
Date Insider Type Main position Quantity % Market Cap.
7/13/26 Tax

Chief Financial Officer

-5,166 0.0134%
7/10/26 Free

Chief Executive Officer

10,454 0.0271%
6/25/26 Free

Director

78,704 0.2037%
Change 5-day change 1-year change 3-year change Capi.($)
-5.27%-18.18%-54.77%+12.92% 36.71M
+0.97%+10.37%-17.80%-9.09% 175B
+0.11%-0.34%-7.05%-6.78% 106B
-1.27%-0.70%+3.80%+57.17% 59.91B
+0.32%-1.08%+40.76%+61.06% 51.95B
-2.33%+0.42%-13.63%-41.35% 43.58B
-2.29%-4.19% - - 33.65B
-1.25%-0.86%-9.77%-42.07% 29.58B
-1.65%-2.05%+67.06%-6.98% 25.31B
-1.55%-1.19%-4.93%-6.81% 21.23B
Average -1.42%-0.57%+0.41%+2.01% 54.71B
Weighted average by Cap. -0.31%+3.25%-1.60%+1.78%

Financials

2026 *2027 *
Net sales 44.43M 38.95M 36M 33.11M 62.47M 4.28B 63.47M 430M 169M 2.1B 167M 163M 7.22B 50.19M 43.99M 40.66M 37.4M 70.56M 4.84B 71.69M 486M 191M 2.37B 188M 184M 8.16B
Net income -13.04M -11.43M -10.57M -9.72M -18.34M -1.26B -18.63M -126M -49.53M -615M -48.98M -47.91M -2.12B -10.68M -9.36M -8.65M -7.96M -15.02M -1.03B -15.26M -103M -40.57M -504M -40.11M -39.24M -1.74B
Net Debt - -
Logo Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Employees
195
Date Price Change Volume
26-07-20 US$0.9000 -5.27% 380,489
26-07-17 US$0.9501 -9.51% 886,351
26-07-16 US$1.050 -5.41% 284,551
26-07-15 US$1.110 +0.91% 164,285
26-07-14 US$1.100 0.00% 235,915
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.9000USD
Average target price
4.420USD
Spread / Average Target
+391.11%

Quarterly revenue - Rate of surprise